West Pharmaceutical Services revenue and financials
$372.64Change from previous close: −1.09%Absolute change: −$4.12
In the fiscal year ended December 2025, West Pharmaceutical Services reported revenue of $3.07B (+6.25% year over year). Net income was $493.7M, a net margin of 16.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.25%
- 2025 vs 2024
- Net income growth
- +0.20%
- 2025 vs 2024
- Net margin
- 16.1%
- 2024: 17.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 872 | 845 | 805 | 805 | 767 | 698 | 749 | 747 | 702 | 695 | 732 | 747 |
| Cost of revenue | 543 | 549 | 501 | 510 | 493 | 466 | 475 | 482 | 472 | 465 | 454 | 459 |
| Gross profit | 329 | 296 | 304 | 294 | 274 | 232 | 274 | 265 | 230 | 230 | 278 | 288 |
| Selling, general and administrative | 112 | 99.5 | 108 | 101 | 94.5 | 86.6 | 83.3 | 81.9 | 83.0 | 86.7 | 90.7 | 89.0 |
| Research and development | 19.7 | 15.8 | 21.8 | 17.1 | 19.1 | 16.3 | 18.5 | 15.5 | 17.5 | 17.6 | 18.4 | 16.4 |
| Operating income | 196 | 183 | 174 | 176 | 160 | 129 | 172 | 167 | 130 | 126 | 168 | 183 |
| EBIT | 196 | 183 | 174 | 176 | 160 | 129 | 172 | 167 | 130 | 126 | 168 | 183 |
| EBITDA | 242 | 229 | 221 | 219 | 201 | 169 | 213 | 207 | 168 | 161 | 204 | 219 |
| Interest expense | 2.6 | 1.9 | -0.2 | 0.2 | 0.1 | 0.4 | — | 0.7 | 1.5 | 1.6 | 1.2 | 2.9 |
| Pre-tax income | 186 | 184 | 165 | 174 | 162 | 114 | 167 | 168 | 133 | 132 | 172 | 191 |
| Income tax | 32.2 | 44.7 | 33.3 | 34.0 | 30.2 | 24.1 | 36.8 | 32.4 | 21.9 | 16.4 | 34.5 | 29.4 |
| Net income | 154 | 139 | 132 | 140 | 132 | 89.8 | 130 | 136 | 111 | 115 | 137 | 161 |
| Net income to common shareholders | 154 | 139 | 132 | 140 | 132 | 89.8 | 130 | 136 | 111 | 115 | 137 | 161 |
| Basic EPS | 2.18 | 1.93 | 1.83 | 1.94 | 1.83 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 |
| Diluted EPS | 2.15 | 1.92 | 1.82 | 1.92 | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.82 | 2.14 |
| Average shares (basic) | 70.8 | 72.0 | 72.3 | 72.2 | 72.2 | 72.5 | 72.7 | 72.8 | 73.0 | 73.5 | 74.1 | 74.3 |
| Average shares (diluted) | 71.3 | 72.4 | 72.7 | 72.6 | 72.5 | 73.0 | 73.3 | 73.4 | 73.7 | 74.3 | 75.0 | 75.3 |
| Dividend per share | 0.22 | 0.22 | 0.22 | 0.21 | 0.21 | 0.21 | 0.21 | 0.20 | 0.20 | 0.20 | 0.20 | 0.19 |